Details for Patent: 8,870,827

Which drugs does patent 8,870,827 protect, and when does it expire?

Patent 8,870,827 protects EPIPEN and EPIPEN JR. and is included in one NDA.

This patent has forty-seven patent family members in eighteen countries.

Summary for Patent: 8,870,827

Title:	Automatic injector
Abstract:	An automatic injector dispenses a predetermined dose of medicament without a user having to manually force the needle into an injection site. The automatic injector includes a needle cover having a locked retracted position with respect to the injector housing prior to a medicament dispensing operation. The needle cover is operative to engage an injection site prior to a medicament dispensing operation.
Inventor(s):	Young; Matthew Egerton (Over Cambs, GB), Raven; Sophie Rebecca (Swavesey Cambs, GB), Hurlstone; Christopher John (Newport Saffron Walden, GB), Rochford; Craig Malcolm (Monxton Andover Hants, GB), Mathews; Colin James (Godmanchester Huntingdon, GB), Hill; Robert L. (Abingdon, MD), Wilmot; John Glyndwr (Mount Airy, MD)
Assignee:	Meridian Medical Technologies, Inc. (Columbia, MD)
Application Number:	12/857,641
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,870,827
Patent Claim Types: see list of patent claims	Dosage form; Use;

Drugs Protected by US Patent 8,870,827

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mylan Speciality Lp	EPIPEN	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	019430-001	Dec 22, 1987	AB	RX	Yes	Yes			Y
Mylan Speciality Lp	EPIPEN JR.	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	019430-002	Dec 22, 1987	AB	RX	Yes	Yes			Y

International Family Members for US Patent 8,870,827

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2005271355
Australia	2010201665
Australia	2013222015
Canada	2576776
Canada	2683253